30 September 2024
Kia ora, In this issue Insights from our Executive Director The more I work in this role the more excited I am about the convergence of once-siloed technologies across multidisciplinary teams. Recently, we had the privilege of attending the Aerospace Summit in Christchurch, where we see the convergence of biology, chemistry, physics and data, all under … Continue reading "NZ potato-tech company CropLogic drops 23pc on ASX debut"
Read More
03 September 2024
In this issue Insights from our Executive Director During the last month there has been plenty of discussion in the media regarding gene technologies – should our companies and researchers have access to technology the rest of the world currently has access to? Special thanks to Dr Revel Drummond, Plant and Food Research and Dr … Continue reading "NZ potato-tech company CropLogic drops 23pc on ASX debut"
Read More
02 September 2024
We can’t wait to reconnect at Aotearoa New Zealand’s 2025 Life Science Summit – Uniting biology and technology to unleash potential. 18-19 March, 2025 at Tākina Wellington Convention and Exhibition Centre. Click here to pop it in your calendar now. The NZ government’s decision to set up a biotech regulator will prove a major boost for industries using … Continue reading "NZ potato-tech company CropLogic drops 23pc on ASX debut"
Read More
21 June 2024
It has been another busy month for biotech. More than 35 Kiwis travelled to the BIO International Convention in San Diego.
Read More
06 March 2024
In this issue Insights from our Executive Director This year feels like it’s going to be a fast game, but a good game for the biotech sector! I am incredibly positive about the reception from the new Government and its associated agencies regarding gene technologies regulations and their updating. However, I don’t think we will … Continue reading "NZ potato-tech company CropLogic drops 23pc on ASX debut"
Read More
Kiwi agtech play CropLogic’s ASX debut disappointed investors, finishing its first day down 23 per cent from its IPO price at 15.5c. The company, which offers crop management technology-as-a-service focused, for now, on potato crops, raised its target $8 million during the IPO, selling 40 milli
September 12, 2017
Australian life sciences investment firm BioScience Managers has chosen a robotic exercise assist device (REX) as its first investment for the Biomedical Translation Fund. The REX Bionics robotic device has been in development for over a decade and has racked up thousands of hours of user experie
September 12, 2017
Tru-Test Corp has hired Simon Mander to lead the agritech company as it looks to build earnings after a hard round of cost-cutting in response to last year’s dairy downturn. Mander started at the Auckland-based company today, replacing Greg Muir who stepped down after more than eight years in t
September 11, 2017
Twenty years ago this week, husband and wife Dr Hartley Atkinson and Marree Atkinson, started AFT Pharmaceuticals (AFT) in a room off their home garage. Last year the NZX and ASX listed company earned revenue of NZ$70M and has a market capitalisation of around NZ$250M. Reflecting on 20 years in
August 31, 2017
Upside Biotechnologies appoints leading US life sciences executive to Board Regenerative medicine start-up, Upside Biotechnologies, has appointed Boston-based Dr Daniel R. Marshak Ph.D. to its Board. New Zealand-based Upside is developing an advanced, world-class skin replacement treatment for p
August 23, 2017
The New Zealand Government announced an investment of up to NZ$35 million over seven years in Genomics Aotearoa (GA), a new collaborative science organisation supporting advanced genomics research. Genomics Aotearoa is an alliance led by the University of Otago and includes the Universities
August 21, 2017
A trial for the treatment for deadly peanut allergy at the Murdoch Children’s Research Institute (MCRI) has shown the strongest evidence yet that a cure may be possible. At the end of the original trial in 2013, 82% of children who received the oral immunotherapy were deemed tolerant to peanuts
August 17, 2017
Monsanto Company (NYSE: MON) and ToolGen, Inc. (KONEX, 199800), a biotechnology company specializing in genome editing, announced today that the companies have reached a global licensing agreement for the use of ToolGen's CRISPR technology platform to develop agricultural products. ToolGen is an
August 17, 2017
FOR bovine reproduction expert Luiz Porto it’s all about producing better beef. The Brazilian trained vet said that’s achieved by taking the genetics of the best performing animals and by using In Vitro Fertilisation (IVF), rapidly decreasing the interval generation t
August 16, 2017